Physician profile
David M Mann
NPI 1619362670
$12,591.01
in general payments reported to CMS, 2019-2025
16 companies · $3,828 in 2025
The $3,828 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,668 · 2023: $2,467 · 2024: $4,628 · 2025: $3,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,130 · Food and Beverage: $3,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,129.60 |
| Food and Beverage | $3,793.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. Dba Accelus | $3,019.11 | 2024 | |
| Cerapedics INC. | $2,213.79 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $1,616.61 | 2023 | Excelsiusgps Robotic Navigation System |
| Seaspine Orthopedics Corporation | $1,342.75 | 2022 | |
| Providence Medical Technology, INC. | $1,258.59 | 2025 | |
| Centinel Spine, LLC | $879.49 | 2024 | Prodisc L |
| Medtronic, INC. | $841.46 | 2022-2025 | Unid_pass, Catalyft Pl Expandable Interbody System, Graftonand Grafton Plusdemineralized Bone Matrix (Dbm) |
| Kyocera Medical Technologies, INC. | $408.06 | 2024-2025 | |
| Si-Bone, INC. | $320.38 | 2022-2025 | |
| Stryker Corporation | $207.77 | 2022-2024 | Duramatrix, Universal Neuro 3 |
| Boston Scientific Corporation | $178.51 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Zimvie INC. | $145.20 | 2023 | |
| Abbott Laboratories | $72.99 | 2025 | Eterna |
| Medical Device Business Services, INC. | $32.00 | 2022 | |
| Innovasis INC | $28.79 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $25.51 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.